Fingerprint
Dive into the research topics of 'Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Caroline J. Coats*, Ahmad Masri, SEQUOIA‐HCM Investigators, Michael E. Nassif, Roberto Barriales-Villa, Michael Arad, Nuno Cardim, Lubna Choudhury, Brian Claggett, Hans Dirk Düngen, Pablo Garcia-Pavia, Albert A. Hagège, James L. Januzzi, Matthew M.Y. Lee, Gregory D. Lewis, Chang Sheng Ma, Martin S. Maron, Zi Michael Miao, Michelle Michels, Iacopo Olivotto
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
6
Citations
(Scopus)
31
Downloads
(Pure)